InsidersTradesSigma
Follow the 浩欧博 share price and the full directors' dealings record of the company, a listed equity based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 浩欧博 has recorded 3 insider filings. Market capitalisation: €5.7bn. The latest transaction was disclosed on 6 July 2026 (Sale). Among the most active insiders: 陈小三. The full history is free.
3
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€181,250
3 ops.
Sell Volume
4Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,929 of 28,892 companies
49.2
score / 100
Value37
Quality62
FCF yld-0.0%
Earn yld0.4%
EV/EBITDA·
ROE3.4%
Gross mgn58%
Net mgn5.8%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 July 2026
About 浩欧博
浩欧博 is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and distribution of pharmaceutical products.